SAN DIEGO, July 26, 2018 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology ...
News
- Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ...
- Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ...
About Halozyme Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies that ...
- A pet food startup backed by Peter Thiel is pursuing lab-grown mouse meat — but some people ...
So the long-time vegan, who previously founded the Silicon Valley biotech startup hub IndieBio, created a startup called Wild Earth that's making ...
- Meet 'Mr. Birthday,' a volunteer who throws foster kids their first birthday party
SAN ANTONIO — Roy Ruiz is more than a man who brings cake, ice cream, and goodies to the Davidson Respite House. To the ... The 41-year-old is an adjunct biomedical equipment instructor at St. Philip's College. This fall, he's ...
- VelocityTX, EPIcenter Complete First San Antonio Pre-Incubator Group
San Antonio—A “pre-incubator” program launched earlier this year by two ... Founded by bioscience and tech economic development group Texas ...